LXRX

Lexicon Pharmaceuticals Inc.

Price

$2.41

return (12m)

107.76%

p/e

-16.52

p/bv

5.78

DIVIDEND YIELD

0.00%

LXRX price

Lexicon Pharmaceuticals

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment LXRX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

3.88%

3 months

8.07%

1 year

107.76%

2 years

42.60%

5 years

-37.89%

10 years

-84.51%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals LXRX

Valuation

P/E

-16.52

Sector -4.38

Industry -4.38

P/BV

5.78

Sector 2.02

Industry 2.02

P/Revenue (PSR)

24.35

Sector -4.40

Industry -4.40

EV/EBITDA

-29.95

Sector -263.09

Industry -263.09

EV/EBIT

-29.84

Sector -702.90

Industry -702.90

P/EBITDA

-19.33

Sector -4.39

Industry -4.39

P/EBIT

-19.15

Sector -4.73

Industry -4.73

P/Total Assets

4.04

Sector 1.49

Industry 1.49

P/Net Current Assets

8.34

Sector -11.70

Industry -11.70

P/Working Capital

5.55

Sector -3.19

Industry -3.19

EPS

-0.14

Sector -2.14

Industry -2.14

BVPS

0.40

Sector 1.85

Industry 1.85

Efficiency

Gross Margin

99.13%

Sector 36.74%

Industry 36.74%

EBITDA Margin

-4,211.59%

Sector -16,244.81%

Industry -16,244.81%

EBIT Margin

-4,227.54%

Sector -4,202,541.34%

Industry -4,202,541.34%

Operating Margin

-100.00%

Sector -38.22%

Industry -38.22%

Net Profit Margins

-100.00%

Sector -39.69%

Industry -39.69%

Asset Turnover

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

-35.01%

Sector -65.14%

Industry -65.14%

ROA

-24.44%

Sector -65.53%

Industry -65.53%

ROIC

-139.99%

Sector -2,103.35%

Industry -2,103.35%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

13.36

Sector 2.90

Industry 2.90

Net Debt / EBITDA

4.79

Sector -6.07

Industry -6.07

Net Debt / EBIT

4.77

Sector -8.26

Industry -8.26

Net Debt / Equity

-0.80

Sector -1.07

Industry -1.07

Gross Debt / Equity

0.29

Sector -0.05

Industry -0.05

Equity/Assets

0.70

Sector 0.41

Industry 0.41

Liabilities/Assets

0.30

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

169.80%

Sector -

Industry -

5Y Earnings CAGR

-6.98%

Sector -

Industry -

Fundamentals LXRX

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
LXRX Lexicon Pharmaceuticals Inc.	$2.41	99.17%	0.00%	-16.52	5.78	-35.01%	-100.00%
JNJ Johnson & Johnson	$273.41	58.46%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.24	21.45%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$265.97	33.11%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.48	-9.14%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$152.20	87.95%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$164.95	4.92%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.61	46.95%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.68	-48.52%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$840.84	43.05%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$442.36	55.11%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$107.62	56.06%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$853.71	27.85%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$552.06	41.60%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$234.85	58.85%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$39.93	9.67%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$221.56	63.02%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

LXRX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Lexicon Pharmaceuticals

Lexicon Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (1 people)

United States

31 years

Founded: 1995

2000

Time since IPO - 26 years

78

Employees

Lexicon Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $1.01 billion, with shareholders equity totaling $174.53 million.

The company employs approximately 78 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Lexicon Pharmaceuticals Inc. reported $41.46 million in revenue, generating net income of $-61.11 million.

Key financial metrics include a P/E ratio of -16.52, a price-to-book (P/B) ratio of 5.78, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker LXRX.

Market cap

$1.01 billion

Net worth

$174.53 million

$174,530,000.00

Assets

$250.06 million

$250,060,000.00

Total Shares Outstanding

438.00 million

438,000,000

Average Daily Trading Volume

$3.48 million

$3,481,964.70

Sector

Health Care

Industry

Biotechnology

LXRX

LXRX revenue and profits

Financial Results LXRX

DRAG THE FRAME TO SEE MORE DATA

LXRX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$853.71 22,07% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$234.85 55,51% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$265.97 31,23% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$152.20 86,97% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$164.95 5,00% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.24 21,16% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$853.71 22,07% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$234.85 55,51% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$265.97 31,23% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$152.20 86,97% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$164.95 5,00% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.24 21,16% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of Lexicon Pharmaceuticals (LXRX) today?

A cotação de Lexicon Pharmaceuticals (LXRX) hoje está em US$ 2.41, com uma variação de 107.76% em relação ao último ano. A cotação de Lexicon Pharmaceuticals (LXRX) iniciou o ano negociando na casa dos US$ 1.15 e hoje está em US$ 2.41. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Lexicon Pharmaceuticals (LXRX) e dados de ações do Ibovespa e mercados internacionais.

Quando Lexicon Pharmaceuticals (LXRX) paga dividendos?

Lexicon Pharmaceuticals (LXRX) não distribuiu dividendos no último ano.

Is Lexicon Pharmaceuticals (LXRX) a good investment?

Atualmente, Lexicon Pharmaceuticals (LXRX) está cotada a US$ 2.41, com um P/L de -16.52, representando um desvio de -635% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 107.76 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 107.76%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Lexicon Pharmaceuticals (LXRX) stock?

Investir em ações de Lexicon Pharmaceuticals (LXRX) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Lexicon Pharmaceuticals (LXRX) yield today?

A rentabilidade de Lexicon Pharmaceuticals (LXRX) foi de 3.88% no último mês, 107.76% no último ano e -37.89% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Lexicon Pharmaceuticals (LXRX) hoje, o investimento total seria de US$ 241.00, com base na cotação atual de US$ 2.41.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 500.70
Em 5 anos: US$ 149.69
Em 10 anos: US$ 37.33

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

LXRX

Lexicon Pharmaceuticals Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment LXRX

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING LXRX WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Lexicon Pharmaceuticals

Lexicon Pharmaceuticals Inc.

United States

31 years

2000

78

PROFIT X PRICE LXRX

Financial Results LXRX

LXRX cash flow

Asset, Revenue and Profit Growth - LXRX

LXRX balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions